Catalent, a provider of development services for biopharma and consumer health partners, has purchased Metrics Contract Services, a full-service specialty contract development and manufacturing organization, for $475 million from Mayne Pharma Group Ltd.

The deal will enhance Catalent’s offerings in integrated oral solid formulation development, manufacturing and packaging. The purchase additionally comes with a 333,000 square-foot facility located in Greenville, NC that offers comprehensive abilities to accelerate and reduce risk across customer programs.

“This acquisition will further expand Catalent’s ability to meet our customers’ expectations in fast-growing areas of the business and patient need,” said Dr. Aris Gennadios, group president of Catalent’s pharma & consumer health segment. “The experienced team and consistently improved, state-of-the-art facility in Greenville will provide Catalent’s customers with immediate, fit-for-scale capacity for in-demand highly potent drugs and other oral solid small-to-mid-size batch needs. This capacity is particularly important for customers with R&D pipelines featuring accelerated, orphan, and rare disease programs for oncology and other important therapeutic areas.”